SRGA

Surgalign Stock Price

1.50
0.03 (2.04%)
Upgrade to Real-Time
Afterhours (Closed)
1.50

Low
1.42

52 Week Range

High
3.29

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Surgalign Holdings Inc SRGA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 2.04% 1.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.50 1.45 1.509 1.46 1.47
Bid Price Ask Price Spread News
1.49 1.51 0.02 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
17,237 6,223,229 $ 1.47 $ 9,169,088 1,715,815 1.42 - 3.29
Last Trade Time Type Quantity Stock Price Currency
19:59:46 50 $ 1.49 USD

Surgalign Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 165.55M 110.37M 98.48M $ 182.06M $ -44.04M -0.44 -4.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.99M 10.20%

more financials information »

Surgalign News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRGA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.701.751.421.534,041,652-0.20-11.76%
1 Month1.501.981.421.642,084,1750.000.0%
3 Months2.542.611.421.841,474,681-1.04-40.94%
6 Months2.523.271.422.151,624,655-1.02-40.48%
1 Year3.263.291.422.161,100,625-1.76-53.99%
3 Years3.263.291.422.161,100,625-1.76-53.99%
5 Years3.263.291.422.161,100,625-1.76-53.99%

Surgalign Description

Surgalign Holdings Inc is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.


Your Recent History
NASDAQ
SRGA
Surgalign
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.